{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:33:54Z","timestamp":1792791234692,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Scientific Research Starting Foundation for Talents of Fujian Medical University Union Hospital","award":["2022XH016"],"award-info":[{"award-number":["2022XH016"]}],"id":[{"id":"https:\/\/ror.org\/055gkcy74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Scientific Research Starting Foundation for Talents of Fujian Medical University Union Hospital","award":["2023XH005"],"award-info":[{"award-number":["2023XH005"]}],"id":[{"id":"https:\/\/ror.org\/055gkcy74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Guangdong Medical Science Research Foundation","award":["B2025409"],"award-info":[{"award-number":["B2025409"]}]},{"name":"the Fujian Provincial Natural Science Foundation of China","award":["2023J01691"],"award-info":[{"award-number":["2023J01691"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Exposure to 3-Methylcholanthrene (3-MC) may be associated with the development and progression of clear cell renal cell carcinoma (ccRCC); however, its underlying molecular mechanisms remain unclear. We conducted differential expression analyses across multiple datasets to identify target genes linked to ccRCC. By integrating SHapley Additive exPlanations (SHAP) with machine learning algorithms, network toxicology and molecular docking, we investigated the binding interactions between 3-MC and these target proteins. A total of 99 genes were identified as potential targets involved in 3-MC-induced ccRCC pathogenesis. Four core genes (GPC3, PIK3C2G, PPARA, and TRPA1) were selected through machine learning approaches. SHAP analysis demonstrated the combined contribution of these genes to the model\u2019s predictive performance. GPC3, PIK3C2G, and PPARA were significantly downregulated, whereas TRPA1 was upregulated (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). Survival analysis using data from The Cancer Genome Atlas (TCGA) revealed significant differences in patient survival based on the expression levels of these genes. Molecular dynamics simulations validated the structural stability of the interaction between 3-MC and PPARA. These findings suggest that 3-MC promotes ccRCC pathogenesis by targeting specific genes.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-34526-x","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:36:38Z","timestamp":1767789398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Deciphering the molecular networks of 3-methylcholanthrene-induced clear cell renal cell carcinoma through multi-omics integration"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuzhe","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"34526_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex, A. et al. European association of urology guidelines on renal cell carcinoma: the 2025 update. Eur. Urol. 87, 683\u2013696 (2025).","journal-title":"Eur. Urol."},{"key":"34526_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/cancers13030548","volume":"13","author":"A Kajdasz","year":"2021","unstructured":"Kajdasz, A. et al. Identification of RCC Subtype-Specific MicroRNAs\u2013Meta-Analysis of High-Throughput RCC tumor MicroRNA expression data. Cancers 13, 548 (2021).","journal-title":"Cancers"},{"key":"34526_CR3","doi-asserted-by":"publisher","first-page":"1400431","DOI":"10.3389\/fimmu.2024.1400431","volume":"15","author":"L Jiang","year":"2024","unstructured":"Jiang, L. et al. Mitophagy and clear cell renal cell carcinoma: insights from single-cell and Spatial transcriptomics analysis. Front. Immunol. 15, 1400431 (2024).","journal-title":"Front. Immunol."},{"key":"34526_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.eururo.2015.08.007","volume":"69","author":"J Sch\u00f6del","year":"2016","unstructured":"Sch\u00f6del, J. et al. Hypoxia, Hypoxia-inducible transcription Factors, and renal cancer. Eur. Urol. 69, 646\u2013657 (2016).","journal-title":"Eur. Urol."},{"key":"34526_CR5","doi-asserted-by":"publisher","first-page":"110690","DOI":"10.1016\/j.envres.2020.110690","volume":"194","author":"K Steenland","year":"2021","unstructured":"Steenland, K. & Winquist, A. PFAS and cancer, a scoping review of the epidemiologic evidence. Environ. Res. 194, 110690 (2021).","journal-title":"Environ. Res."},{"key":"34526_CR6","first-page":"444","volume":"8","author":"P Boffetta","year":"1997","unstructured":"Boffetta, P., Jourenkova, N. & Gustavsson, P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control. 8, 444\u2013472 (1997).","journal-title":"Cancer Causes Control"},{"key":"34526_CR7","doi-asserted-by":"publisher","first-page":"131681","DOI":"10.1016\/j.chemosphere.2021.131681","volume":"286","author":"Q Xu","year":"2022","unstructured":"Xu, Q. et al. Parental exposure 3-methylcholanthrene disturbed the enterohepatic circulation in F1 generation of mice. Chemosphere 286, 131681 (2022).","journal-title":"Chemosphere"},{"key":"34526_CR8","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.3390\/ijms24065567","volume":"24","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Inhibitory effects of 3-Methylcholanthrene exposure on Porcine oocyte maturation. Int. J. Mol. Sci. 24, 5567 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"34526_CR9","doi-asserted-by":"publisher","first-page":"144839","DOI":"10.1016\/j.scitotenv.2020.144839","volume":"771","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. DNA methylation and hydroxymethylation associated with gene expression regulatory network during 3-methylcholanthrene induced lung cell malignant transformation. Sci. Total Environ. 771, 144839 (2021).","journal-title":"Sci. Total Environ."},{"key":"34526_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/bjc.2011.343","volume":"105","author":"CR Daniel","year":"2011","unstructured":"Daniel, C. R. et al. Meat-cooking mutagens and risk of renal cell carcinoma. Br. J. Cancer. 105, 1096\u20131104 (2011).","journal-title":"Br. J. Cancer"},{"key":"34526_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13046-019-1337-2","volume":"38","author":"F Cirillo","year":"2019","unstructured":"Cirillo, F. et al. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs). J. Exp. Clin. Cancer Res. 38, 335 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"34526_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0090-9556(25)06663-2","volume":"23","author":"H Kim","year":"1995","unstructured":"Kim, H., Reddy, S. & Novak, R. F. 3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue. Drug Metab. Dispos. 23, 818\u2013824 (1995).","journal-title":"Drug Metab. Dispos."},{"key":"34526_CR13","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1038\/s41598-019-40757-6","volume":"9","author":"CC Chang","year":"2019","unstructured":"Chang, C. C. et al. Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 Inhibition and RhoA reactivation. Sci. Rep. 9, 4606 (2019).","journal-title":"Sci. Rep."},{"key":"34526_CR14","doi-asserted-by":"publisher","first-page":"153847","DOI":"10.1016\/j.tox.2024.153847","volume":"506","author":"S Huang","year":"2024","unstructured":"Huang, S. Analysis of environmental pollutant bisphenol F elicited prostate injury targets and underlying mechanisms through network toxicology, molecular docking, and multi-level bioinformatics data integration. Toxicology 506, 153847 (2024).","journal-title":"Toxicology"},{"key":"34526_CR15","doi-asserted-by":"publisher","first-page":"167904","DOI":"10.1016\/j.scitotenv.2023.167904","volume":"905","author":"S Huang","year":"2023","unstructured":"Huang, S. Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular Docking strategy: acetyl tributyl citrate as an example. Sci. Total Environ. 905, 167904 (2023).","journal-title":"Sci. Total Environ."},{"key":"34526_CR16","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. CB-Dock2: improved protein\u2013ligand blind Docking by integrating cavity detection, Docking and homologous template fitting. Nucleic Acids Res. 50, W159\u2013W164 (2022).","journal-title":"Nucleic Acids Res."},{"key":"34526_CR17","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark, P. & Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J. Phys. Chem. A. 105, 9954\u20139960 (2001).","journal-title":"J. Phys. Chem. A"},{"key":"34526_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-022-01597-7","volume":"21","author":"I Heidegger","year":"2022","unstructured":"Heidegger, I. et al. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4\/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Mol. Cancer. 21, 132 (2022).","journal-title":"Mol. Cancer"},{"key":"34526_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1097\/JS9.0000000000002070","volume":"111","author":"F Li","year":"2025","unstructured":"Li, F., Liang, J. & Wei, X. Epigenetic modification of castor zinc finger 1 (CASZ1) is associated with tumor microenvironments and prognosis of clear cell renal cell carcinoma. Int. J. Surg. 111, 988\u2013997 (2025).","journal-title":"Int. J. Surg."},{"key":"34526_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"34526_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/toxsci\/kfy153","volume":"165","author":"M H\u00fd\u017ed\u2032alov\u00e1","year":"2018","unstructured":"H\u00fd\u017ed\u2032alov\u00e1, M. et al. Aryl hydrocarbon Receptor-Dependent metabolism plays a significant role in Estrogen-Like effects of polycyclic aromatic hydrocarbons on cell proliferation. Toxicol. Sci. 165, 447\u2013461 (2018).","journal-title":"Toxicol. Sci."},{"key":"34526_CR22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/ijms22020752","volume":"22","author":"A Paris","year":"2021","unstructured":"Paris, A., Tardif, N., Galibert, M. D. & Corre, S. AhR and cancer: from gene profiling to targeted therapy. Int. J. Mol. Sci. 22, 752 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"34526_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrc3846","volume":"14","author":"IA Murray","year":"2014","unstructured":"Murray, I. A., Patterson, A. D. & Perdew, G. H. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat. Rev. Cancer. 14, 801\u2013814 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"34526_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ijc.29398","volume":"137","author":"M Ishida","year":"2015","unstructured":"Ishida, M. et al. Activation of Aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke. Intl J. Cancer. 137, 299\u2013310 (2015).","journal-title":"Intl J. Cancer"},{"key":"34526_CR25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/genes15091167","volume":"15","author":"F Gregoris","year":"2024","unstructured":"Gregoris, F., Minervini, G. & Tosatto, S. C. E. Silico exploration of AHR-HIF pathway interplay: implications for therapeutic targeting in CcRCC. Genes (Basel). 15, 1167 (2024).","journal-title":"Genes (Basel)"},{"key":"34526_CR26","doi-asserted-by":"publisher","first-page":"104196","DOI":"10.1016\/j.isci.2022.104196","volume":"25","author":"D Aibara","year":"2022","unstructured":"Aibara, D. et al. Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation. iScience 25, 104196 (2022).","journal-title":"iScience"},{"key":"34526_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","volume":"61","author":"S Mandard","year":"2004","unstructured":"Mandard, S., M\u00fcller, M. & Kersten, S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 61, 393\u2013416 (2004).","journal-title":"Cell. Mol. Life Sci."},{"key":"34526_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-022-01726-7","volume":"21","author":"R Wang","year":"2022","unstructured":"Wang, R. et al. WY-14643 attenuates lipid deposition via activation of the PPAR\u03b1\/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in CcRCC. Lipids Health Dis. 21, 121 (2022).","journal-title":"Lipids Health Dis."},{"key":"34526_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/cancers14030795","volume":"14","author":"M Goujon","year":"2022","unstructured":"Goujon, M. et al. A Double-Negative feedback interaction between miR-21 and PPAR-\u03b1 in clear renal cell carcinoma. Cancers (Basel). 14, 795 (2022).","journal-title":"Cancers (Basel)"},{"key":"34526_CR30","doi-asserted-by":"publisher","first-page":"19R","DOI":"10.1093\/glycob\/11.3.19R","volume":"11","author":"J Filmus","year":"2001","unstructured":"Filmus, J. Glypicans in growth control and cancer. Glycobiology 11, 19R\u201323R (2001).","journal-title":"Glycobiology"},{"key":"34526_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bcp.2019.06.020","volume":"168","author":"SP Kaur","year":"2019","unstructured":"Kaur, S. P. & Cummings, B. S. Role of glypicans in regulation of the tumor microenvironment and cancer progression. Biochem. Pharmacol. 168, 108\u2013118 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"34526_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.omto.2022.04.003","volume":"25","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. Chimeric anti-GPC3 sFv-CD3\u03b5 receptor-modified T cells with IL7 co-expression for the treatment of solid tumors. Mol. Therapy - Oncolytics. 25, 160\u2013173 (2022).","journal-title":"Mol. Therapy - Oncolytics"},{"key":"34526_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fonc.2020.00625","volume":"10","author":"S Majo","year":"2020","unstructured":"Majo, S., Courtois, S., Souleyreau, W., Bikfalvi, A. & Auguste, P. Impact of extracellular matrix components to renal cell carcinoma behavior. Front. Oncol. 10, 625 (2020).","journal-title":"Front. Oncol."},{"key":"34526_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1006\/geno.1998.5621","volume":"54","author":"M Rozycka","year":"1998","unstructured":"Rozycka, M. et al. cDNA cloning of a third human C2-Domain-Containing class II phosphoinositide 3-Kinase, PI3K-C2\u03b3, and chromosomal assignment of this gene (PIK3C2G) to 12p12. Genomics 54, 569\u2013574 (1998).","journal-title":"Genomics"},{"key":"34526_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano, A. et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer. 22, 138 (2023).","journal-title":"Mol. Cancer"},{"key":"34526_CR36","doi-asserted-by":"publisher","first-page":"111425","DOI":"10.1016\/j.cellsig.2024.111425","volume":"124","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. TAF1D promotes tumorigenesis and metastasis by activating PI3K\/AKT\/mTOR signaling in clear cell renal cell carcinoma. Cell. Signal. 124, 111425 (2024).","journal-title":"Cell. Signal."},{"key":"34526_CR37","doi-asserted-by":"publisher","first-page":"174185","DOI":"10.1016\/j.ejphar.2021.174185","volume":"904","author":"AS De Almeida","year":"2021","unstructured":"De Almeida, A. S., Bernardes, L. D. B. & Trevisan, G. TRP channels in cancer pain. Eur. J. Pharmacol. 904, 174185 (2021).","journal-title":"Eur. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34526-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34526-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34526-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:55:25Z","timestamp":1770026125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34526-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34526"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34526-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were conducted in accordance with the relevant guidelines and regulations (2023KJT072) approved by the Ethics Committee of Fujian Medical University Union Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"4411"}}